Ipsen seeks to invest in early stage innovation with Arix

Life sciences investment firm Arix Bioscience plc (LSE:ARIX) partnered with Ipsen Group (Euronext:IPN; Pink:IPSEY) to create new companies focused on developing and commercializing "innovative therapies" in undisclosed indications. Arix declined to disclose further details about therapies or indications the partners would build newcos around.

The partners said Arix will provide access to its professional and scientific advisor network and Ipsen will have opportunities to invest in Arix's new and existing businesses...